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Proteins play a crucial role in metabolism, in maintaining fluid and acid-base balance and antibody
synthesis. Dietary proteins are important nutrients and are classified into: 1) animal proteins (meat, fish,
poultry, eggs and dairy), and, 2) plant proteins (legumes, nuts and soy). Dietary modification is one of the
most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular
(CV) disease (CVD) by attenuating related risk factors. The CVD burden is reduced by optimum diet
through replacement of unprocessed meat with low saturated fat, animal proteins and plant proteins. In
view of the available evidence, it has become acceptable to emphasize the role of optimum nutrition to
maintain arterial and CV health. Such healthy diets are thought to increase satiety, facilitate weight loss,
and improve CV risk. Different studies have compared the benefits of omnivorous and vegetarian diets.
Animal protein related risk has been suggested to be greater with red or processed meat over and above
poultry, fish and nuts, which carry a lower risk for CVD. In contrast, others have shown no association of
red meat intake with CVD.
The aim of this expert opinion recommendation was to elucidate the different impact of animal vs
vegetable protein on modifying cardiometabolic risk factors. Many observational and interventional
studies confirmed that increasing protein intake, especially plant-based proteins and certain animal-
based proteins (poultry, fish, unprocessed red meat low in saturated fats and low-fat dairy products)
have a positive effect in modifying cardiometabolic risk factors. Red meat intake correlates with
increased CVD risk, mainly because of its non-protein ingredients (saturated fats). However, the way red
meat is cooked and preserved matters. Thus, it is recommended to substitute red meat with poultry or
fish in order to lower CVD risk. Specific amino acids have favourable results in modifying major risk
factors for CVD, such as hypertension. Apart from meat, other animal-source proteins, like those found inPanel (ILEP) & Head of Department of Hypertension, Medical University of Lodz, 281/289 Rzgowska St., 93-338, Lodz,
nd Clinical Medicine, Umeå University, Umeå, Sweden.
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Proteins are well known for their kinetic, catalytic, structural
and signalling roles [1,2]. Proteins also play a crucial role in fluid
and acid-base balance as well as antibody synthesis [1,2]. Unlike
lipids and carbohydrates, proteins contain nitrogen that creates
amino groups found in amino acids (essential and non-essential),
nucleotides and hormones [1]. Dietary proteins are important nu-
trients and are classified as animal (meat, fish, poultry, eggs and
dairy) and plant proteins (beans, lentils, nuts and soy) [2]. While
animal proteins tend to contain a good balance of required amino
acids (i.e. complete sources) some plant proteins are low in certain
amino acids (i.e. incomplete sources) [1,2].
The cardiovascular (CV) disease (CVD) burden has been shown
to be reduced by optimum, well-balanced diet, with more plant
proteins in addition to low saturated fatty acids (SFA) and unpro-
cessed animal proteins [3]. According to the World Health Orga-
nization (WHO), 17.9 million people die every year from CVD,
representing 31% of worldwide deaths [4]. CVD affects several
arterial vessels (e.g. coronary and peripheral). Dietary modification
has been shown to significantly decrease the risk of coronary heart
disease (CHD), by attenuating related risk factors, such as hyper-
tension (HTN), hyperglycemia, elevated low-density lipoprotein
cholesterol (LDL-C) level, oxidative stress and inflammation [5,6].
In view of the above-mentioned facts, it has become acceptable
to emphasize the role of optimal nutrition to maintain arterial
health. There is however considerable debate regarding which diet
is optimal for specific patients, especially taking into account any
existing risk factors or concomitant disorders [7e9]. Different
studies have compared the benefits of omnivorous and vegetarian
diets [8e12]. Plant proteins may have a different impact on CVD
compared with animal proteins [3]. Epidemiological and inter-
ventional studies attempted to evaluate the respective benefits of
these two types of proteins, but a strict separate impact is difficult
to prove because of the natural mix of dietary proteins people
usually consume in addition to the effect of other non-protein
compounds on CVD risk factors [3]. Some studies suggested that
diets rich in animal protein with low fiber increase CVD risk [3] via
their adverse effects on blood lipids and blood pressure (BP), but
this effect has not been demonstrated in controlled trials
[3,8,10e12]. Furthermore, animal protein related risk has been
suggested to be greater with red or processed meat compared with
poultry, fish and nuts, which carry a lower risk for CHD. In contrast
to these findings, other studies demonstrated no association be-
tween red meat and CHD [2,4,10]. Such inconsistent data might be
associated with the fact that animal protein might modulate CVD
risk factors by different amino acids, with cysteine, glutamate,
arginine, taurine and tryptophan having a modifying effect on BP,
by reducing weight, increasing glomerular filtration rate (GFR),
reducing vascular resistance and other actions [3,8,10e12].
The aim of the present expert opinion recommendation of the
International Lipid Expert Panel (ILEP), presented in the form of
the Position Paper, is to elucidate the different impact of animal vs
vegetable protein on cardiometabolic risk factors. We also pro-
vide recommendations on the protein content of the optimal
healthy diet.
1.1. Comprehensive literature search and clinical evidence of dietary
protein in modifying cardiometabolic risk factors
A comprehensive literature search was conducted using the
electronic databases: PubMed-Medline, EMBASE, Scopus, Google
Scholar, Web of Science by Clarivate, the Cochrane Central Registry
of Controlled Trials and ClinicalTrial.gov, up to October 2019, using
the following terms: dietary protein OR protein OR animal proteinsPlease cite this article as: Zhubi-Bakija F et al., The impact of type of dietar
factors: A position paper from the International Lipid Expert Panel (ILEP)OR vegetable proteins AND coronary artery disease AND cardio-
metabolic risk factors AND outcome AND randomized controlled
trial (RCT) AND clinical trials AND/OR obesity AND/OR hyperten-
sion AND/OR stroke AND/OR diet AND/OR milk/dairy proteins OR
nuts OR soy OR red meat OR fish AND/OR insulin resistance. The
literature search was limited to studies in humans and articles
published in English. Two reviewers (FZB and GB) independently
evaluated each article. No filters were applied. Additionally, the
abstracts from the most important conferences on the topic were
searched.
The level of evidence and the strength of recommendation of
different protein diets have been weighed and graded according to
predefined scales and are presented in Tables 1 and 2.
Physicians and medical professionals of other specialties treat-
ing patients at different CV risk are encouraged to consider the
Position Paper in the process of evaluating the clinical status of
their patients and to implement lifestyle changes including well-
balanced healthy diet with the optimal protein content. However,
the Position Paper does not override in any way the individual re-
sponsibility of physicians to make appropriate decisions taking into
account the condition of a given patient and in consultation with
that patient, or, where necessary, with the patient's guardian or
caretaker. The authors of the Position Paper are aware that the use
of recommendations depends on several judgment calls that take
into account values and preferences of patients.2. Dietary animal proteins vs plant proteins
The recommendations for protein intake in USA are based on
the Dietary Reference Intakes (DRIs) [13]. The DRIs for protein are
presented as the Estimated Average Requirement (EAR) and the
Recommended Dietary Allowances (RDAs) [13]. For individuals
older than 18 years, the EAR is 0.66 g/kg of body weight and the
RDA is 0.8 g/kg of body weight. A 57 kg woman and a 70 kg man are
considered as the references for EAR and RDA. The values of EAR
38 g/day and the RDA 46 g/day for women and EAR of 46 g/day and
RDA 56 g/day formen are considered as reference values for protein
intake. Based on current evidence, an RDA of 1.0e1.2 g of protein/kg
of body weight to maintain normal calcium and nitrogen meta-
bolism, and to maintain normal renal function, was considered as
normal value in the elderly [13]. On the other hand, in children and
pregnant women the DRIs for protein intake/kg of body weight are
considered to be higher, because of growth needs in this age. For
children aged 1e3 years the RDA is 1.05 g/kg of body weight/day,
for those aged 4e13 years it is 0.95 g/kg of body weight/day, and
14e18years aged children it is 0.85 g/kg of body weight/day [13].
Whereas, for pregnant women of all ages the RDA is 1.1 g/kg of body
weight/day [13]. Athletes also have an increased need for daily
protein, mainly because of their interest to gain muscle mass and to
support higher levels of daily activities. Based on previous studies,
it was suggested that protein intake in athletes should be between
1.2 and 1.7 g/kg/day [13].
Smit et al. [14] calculated age and gender specific estimates of
protein intake using the National Health and Nutrition Examination
Survey (NHANES) 1988e1991 cohort. This study found that in
adults, the average daily protein intake was 80 g/day, from which
69% originated from animal food. In addition, the authors found
that the energy intake values were 2591 ± 39 kcal for men and
1746 ± 18 kcal for women [14]. The recent data from NHANES
2013e2014 showed that the average of protein consuming per day
from the USA inhabitants was 80 g/day: 94 g of protein/day formen,
and 67 g of protein/day for women. However, the data from this
study could not analyse the breakdown of animal food vs plant food
protein [15] (Table 3).y protein, animal versus vegetable, in modifying cardiometabolic risk
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Table 1
Classes of recommendation.
Classes of recommendation Definition Suggested wording to use
Class I Evidence and/or general agreement that a given treatment or procedure is beneficial, useful,
effective
Is recommended/Is indicated
Class II Conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of the given
treatment or procedure
Class IIa Weight of evidence/opinion is in favour of usefulness/efficacy Should be considered
Class IIb Usefulness/efficacy is less well established by evidence/opinion May be considered
Class III Evidence or general agreement that the given treatment or procedure is not useful/effective and
in some cases may be harmful
Is not recommended
Table 2
Level of evidence.
Level of evidence Definition
Level A Data derived from multiple randomized clinical trials or their meta-analysis
Level B Data derived from single randomized clinical trial or large non-randomized studies
Level C Consensus or opinion of the experts and/or small studies, retrospectives studies, registries
Table 3
Recommendations for average and dietary allowance for protein.
Class Level Estimated average
requirement for protein
Dietary allowances
for protein
Safety issues
I B 0.60 g/kg/daya
0.71e1.0 g/kg/dayb
1.1e1.4 g/kg/dayc
0.80 g/kg/daya
0.85e1.1 g/kg/dayb
1.2e1.6 g/kg/dayc
No safety issues
III B >2.0 g/kg/day May accelerate disease progression (e.g. preexisting kidney disease), reduce glycogen
levels, and be detrimental for optimal performance.
a General healthy adult male and female.
b Children and pregnant women.
c Endurance athletes.
F. Zhubi-Bakija et al. / Clinical Nutrition xxx (xxxx) xxx4A protein-rich-diet can limit the consumption of other nutri-
ents (e.g. refined sugars and saturated fat); this should be
factored in when assessing the impact of protein intake on CVD
risk [3]. In the recent paper prepared by the ILEP an increase of
saturated fats and animal proteins consumption was observed in
individuals on low carbohydrate diets (carbohydrate level intake
<200 g/day) [16]. Many observational studies provided evidence
for the health benefit from vegetable proteins, particularly in BP
control and achieving optimum lipid profile [17e19]. Having
evaluated BP in a Seven Days Adventist population, Armstrong
et al. suggested that the lower BP in a vegetarian community
might have been related to them being thin, consuming little
alcohol and a healthy diet as well as a tendency not to smoke [19].
It should be mentioned that the effects of dietary plant protein
are usually not in isolation but integrated with other plant-
based-food components, such as magnesium, potassium and fi-
ber [20,21]. The Nurses’ Health Study found that replacing 1
standard serving of red meat [3oz (85 g)] with different vegetable
protein sources reduced CHD risk by 13e30% [22], similar to the
effect of soy food on CHD in women [23].
In male patients with hypercholesterolemia and normal body
mass index (BMI), the cholesterol level was decreased by replace-
ment of animal protein with soy protein in their diet [24]. In these
patients, 60% of the animal proteins were substituted by soy, after a
diet with 25e30% of energy from fats, 10e12% from proteins, and
the rest from carbohydrates. In addition to basic blood tests, lipid
parameters, anthropometric measurements and endothelial func-
tion were evaluated at baseline and 6 weeks after soy protein diet
replacement. Endothelial function was assessed by flow-mediated
endothelium-dependent dilatation (FMD) and plasmaPlease cite this article as: Zhubi-Bakija F et al., The impact of type of dietar
factors: A position paper from the International Lipid Expert Panel (ILEPthrombomodulin levels [24]. After using a soy protein intake of
19.9 ± 2.2 g/day during the study period, the plant source protein
was greater compared with animal source protein (p < 0.001), but
the weight, waist-hip ratio (WHR) and skin fold thickness of the
subjects were not changed by the soy protein diet. On the other
hand, BMI decreased significantly (25.3 ± 1.3 vs 25.1 ± 1.3 kg/m2,
p¼ 0.03). Plasma total cholesterol (TC), LDL-C and triglycerides (TG)
levels were also significantly decreased (by 15%, 20% and 14%,
respectively) whereas high-density lipoprotein cholesterol (HDL-
C), apolipoprotein (Apo) A1 and lipoprotein (a) (Lp(a)) levels did not
change after the soy protein diet [24]. Leslie et al., in a randomized
study, assessed the effect of plant-based diet (PBD) using specific
dietary advice on vascular function in peripheral artery disease
(PAD) patients [25]. In addition to the lipid profile, C-reactive pro-
tein (CRP), nitric oxide (NO), superoxide dismutase (SOD), vascular
function assessment by brachial artery FMD, carotid intima-media
thickness (cIMT), carotid-femoral pulse wave velocity (PWV), and
brachial-ankle PWVweremeasured. After 4 months on PBD, TC and
LDL-Cwere decreased by 7.6% and 13.6%, respectively (p¼ 0.01), NO
level increased from 7.7 ± 5.3 mmol/L at baseline to
18.7 ± 13.7 mmol/L after 4 months PBD (p < 0.01), whereas there
were no such changes in the control group. After 4 months, FMD
was significantly improved in the PBD group compared with the
control group (8.7 ± 5.6 vs 5.1 ± 0.5%; p ¼ 0.03); moreover, the
ankle-brachial index was also significantly improved by 7.6% [25].
Van Bussel et al. studied dietary intake by food-frequency
questionnaire (FFQ) and measured plasma biomarkers of endo-
thelial dysfunction in 557 participants (aged 59.6 ± 6.9 years) at
increased CVD risk from the CODAM (Cohort on Diabetes and
Atherosclerosis Maastricht) study, who were followed-up for 7y protein, animal versus vegetable, in modifying cardiometabolic risk
), Clinical Nutrition, https://doi.org/10.1016/j.clnu.2020.05.017
F. Zhubi-Bakija et al. / Clinical Nutrition xxx (xxxx) xxx 5years [26]. A higher consumption of fish (per 100 g/week) was
associated with a lower endothelial dysfunction score (b: 0.027;
95% confidence interval [CI]): (0.051, 0.004), whereas con-
sumption of vegetables, fruit, dairy products, alcohol-containing
beverages, or meat, were not related with endothelial dysfunction
over 7 years follow-up. These results showed that consumption of
more lean fish (per 100 g/week), more raw vegetables (per 100 g/d),
and fewer high-fat dairy products (per 100 g/day) were associated
with lower level of endothelial dysfunction [(b: 0.038; 95%
CI: 0.072, 0.005), (b: 0.095; 95% CI: 0.191, 0.000), and
(b: 0.070; 95% CI: 0.131, 0.009), respectively]. On the other
hand, consumption of more fresh fruit (per 100 g/day), wine (per
100mL/week) and poultry (per 100 g/day), and fewer high-fat dairy
products (per 100 g/day) were associated withmuch lower grade of
inflammation [(b: 0.074; 95% CI: 0.133, 0.015), (b:0.006; 95%
CI: 0.013, 0.001), (b:0.247; 95% CI: 0.479, 0.014), and
(b:0.100; 95% CI: 0.182, 0.019), respectively [26].
Most of the available studies have also correlated red meat
intake with increased CV risk and mortality. In a study [22] which
included >80,000 women, red meat intake was related to an
increased CHD risk, but the impact was different with nuts, poultry,
fish and milk protein intake, which lowered the CHD risk in the
same subjects. The consumption of nuts (1 serving/day) lowered by
30% the risk of CHD compared with consumption of red meat (1
serving/day). Consumption of low-fat dairy was associated with
13%, poultry with 19% and fish with 24% lower risk of CHD
compared with consumption of red meat (1 serving/day for all)
[22]. Similar results were reported by Preis et al. who concluded
that high animal protein intake correlated with increased CHD risk
in men [27]. In the European Prospective Investigation into Cancer
and Nutrition (EPIC) cohort, only processed meat increased the risk
for CVD and all-cause mortality but not red meat or poultry [28].
These findings were also reproduced by Micha et al. [29]. The likely
explanation for the worse effect of processed meat is the 400%
more sodium and 50% more nitrates they contain compared with
unprocessed meat [30]. It was shown in an experimental study that
nitrates and their products (e.g. peroxynitrite) promote vascular
dysfunction and atherosclerosis, impair glucose tolerance and
reduce insulin secretion, while streptozocin (a nitrosamine-related
compound), has diabetogenic effect [31]. A nitrite concentration
has been showed to be associated with endothelial dysfunction and
impaired insulin response in adults and was used as a biomarker of
these impairments [32]. On the other hand, salt intake is positively
correlated with BP (through its water retention mechanism) and is
a predictor of left ventricular (LV) mass, which is an important risk
factor for premature CVD [33]. This is the reason for considering
preservatives and sodium content of processed meat as having the
strongest link with CHD risk [22,30e33] (Figs. 1e4, Table 4,
Suppl. Table 1).3. Dietary protein intake and obesity
Proteins may prevent weight gain and may also have beneficial
effect on weight maintenance, mainly by increasing the thermo-
genesis and satiety [34]. The total protein and protein from animal
sources had positive correlation with subsequent body weight
change in the general population, and this correlation was stronger
in women than in men [34]. In contrast, plant protein did not show
any correlation with weight changes. The EPIC study [34], which
included 89,432 subjects followed up for 6.5 years, showed that
higher intake of total protein and protein from animal sources
correlated with subsequent weight gain, particularly in women.Please cite this article as: Zhubi-Bakija F et al., The impact of type of dietar
factors: A position paper from the International Lipid Expert Panel (ILEP)Those women who had 150 kcal higher daily intake had a yearly
weight increase of 78 g (95%CI: 35e120) and 82 g (95%CI: 41e124)
for total and animal protein, respectively. In contrast, the yearly
weight increase was much lower for men compared with women -
29 g (95%CI:1e59) and 30 g (95%CI:8e68), respectively. The diet
with protein sourced from red and processed meat, as well as
poultry were associated with increased weight, whereas the pro-
tein from fish and dairy sources did not correlate with any weight
changes. No significant association of plant protein and protein
from unknown origin consumption with weight changes was also
observed [34].
In another study participants consumed 500e1000 calories less
from the usual daily amount, but with a minimum daily amount of
1000 kcal. Based on the proportion of protein consumption, par-
ticipants were divided into 2 groups: (1) the high protein (HP)
group (22e30% protein, 50e55% carbohydrate and 20e25% fat),
and, (2) standard protein (SP) group (12e20% protein, 55e60%
carbohydrates and 20e30% fats). The waist circumference (WC)
was significantly decreased, from 96.13 ± 8.19 to 90.09 ± 8.62 cm
(p < 0.001), after 8 weeks of protein-rich low-calorie diet inter-
vention [35]. This study showed that the specific dietary inter-
vention reduce visceral fat and it is recommended as a possible
treatment or prevention of visceral obesity [35].
The HELENA (Healthy Lifestyle in Europe by Nutrition in
Adolescence) RCT study [36] was undertaken to assess the role of
plant protein intake in preventing obesity among adolescents in
European countries. Mean total protein intake among subjects was
96 g/day, from which 59% derived from animal protein. Female
participants consumed less total, animal and plant protein male,
and the consumption of these proteins was lower in younger
participants (between 12.5 and 14.9 years of age). Females
consumed 50 g/day animal proteins, compared with 33 g/day plant
proteins, whereas males consumed 66 g/day animal proteins and
43 g/day plant proteins [36]. Underweight subjects consumed less
protein than obese participants. The plant protein intakes had
stronger inverse association with BMI z-score and body fat per-
centage (BF%) compared with animal protein intakes. Animal
protein intake had inverse association with TC, TG, VLDL-C and
leptin, whereas there was a positive associationwith serum fasting
glucose. On the other hand, absolute plant protein intake had in-
verse association with TC, HDL-C, and leptin, but positive associ-
ation with serum fasting glucose. After adjustments for fat intake,
animal protein intake had a positive association with BMI z-score
[36]. Based on these results, the authors suggested that extra high
protein intake may cause imbalance in energy intake and food
consumption. These findings indicate that despite weak positive
association of HDL-C with absolute animal protein intake, plant
protein had stronger protective effect against obesity compared
with animal protein. It was considered that these results were
influenced by the facts that participants of this study exceeded
protein intake based onWHO requirement, and almost 2/3 of them
consumed protein sources were from animal origin rather than
from plants, which could influence to the body weight and body
composition [36].
A parallel-design, RCT showed that after a 12-week eucaloric
high protein (HP) diet with 3 whole eggs/day (equivalent of 1.4 g
protein/kg/day), changes in muscle composition, and car-
diometabolic health were minimal vs standard protein (SP) diet
void of eggs (0.8 g protein/kg/day). The subcutaneous fat to muscle
volume ratio was decreased over time in participants with HP diet
but not in those with SP diet (p¼ 0.031) [37]. After 12-week dietary
intervention, both body weight (3.00 ± 2.43 kg, p ¼ 0.022, partialy protein, animal versus vegetable, in modifying cardiometabolic risk
, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2020.05.017
Fig. 1. The effect of animal proteins on CVD risk factors and their possible mechanisms. CVD, cardiovascular disease; BP, blood pressure; TC, total cholesterol; LDL-C, low density li-
poprotein cholesterol; TG, triglycerides; T2DM, Type 2 Diabetes Mellitus.
F. Zhubi-Bakija et al. / Clinical Nutrition xxx (xxxx) xxx6r2 ¼ 0.246) and body fat (2.25 ± 1.67 kg, p ¼ 0.011, partial
r2¼ 0.266) were reduced in both HP and SP diet groups [36]. On the
other hand, LDL-C concentration (p ¼ 0.015, partial r2 ¼ 0.274) and
hip circumference (p ¼ 0.003, partial r2 ¼ 0.450) were decreased
only after dietary intervention with the SP diet. Moreover, fasting
glucose, insulin concentrations and other cardiometabolic markers
were not influenced by these diets [37].
In the study by Campbell et al. [38], in middle-aged overweight
and obese adults, who were on a 36 weeks resistance and aerobic
exercise intervention, an inverse association of total protein intake
(TPro) and change in total protein intake (CTPro) with body mass,
fat mass (FM) and BMI changes was registered. The authors
observed an inverse association of TPro and CTPro with changes in
body mass, FM and BMI in this study. Changes in body composition
were different (p < 0.05) among study groups that consumed
protein <1.0 g/kg/day (n ¼ 43) vs  1.0 to <1.2 g/kg/day (n ¼ 29)
vs  1.2 g/kg/day (n ¼ 45). After a 36-week exercise training
intervention, the participants of TPro study group with 1.0 to
<1.2 g/kg/day reduced FM and %FM increased percentage of lean
mass (%LM) compared with the lowest TPro, whereas the TProPlease cite this article as: Zhubi-Bakija F et al., The impact of type of dietar
factors: A position paper from the International Lipid Expert Panel (ILEPgroup with 1.2 g/kg/day had intermediate responses on changes
in FM, %FM and %LM [38]. However, the gain in LM did not differ
between study groups. In addition, there was no relation observed
of TPro and CTPro with metabolic syndrome (MetS) indexes [38].
In the study by Tang et al. [39], men who aimed weight main-
tenance reducing their daily energy needs for 750 kcal/day with
either SP (0.8 g protein/kg/day) or HP (1.4 g protein/kg/day) for 12
weeks, lost more lean body mass compared with men that
consumed either standard or high protein content. The weight
reduction in SP group was 10.6 ± 0.6 kg, whereas in HP group
was 9.1 ± 0.7 kg. However, both diet groups had not significant
differences regarding body weight and fat, TC, HDL-C, TG, glucose,
insulin, LDL-C and TC-to-HDL-C ratio. This study also showed that
energy restriction in general effectively improves several clinical CV
health indicators, improves glucose control, but these improve-
ments were not different between SP and HP groups [39].
The findings of the Belgian National Food Consumption Survey
suggest that in a Belgian population, fresh meat, cheese and milk
products are the most important contributors to animal protein
intakes [40]. In the participants of the study from 72 g/day of totaly protein, animal versus vegetable, in modifying cardiometabolic risk
), Clinical Nutrition, https://doi.org/10.1016/j.clnu.2020.05.017
Fig. 2. The effect of plant proteins on CVD risk factors and their possible mechanism. CVD, cardiovascular disease; BP, blood pressure; TC, total cholesterol; LDL-C, low density lipoprotein
cholesterol; TG, triglycerides; T2DM, Type 2 Diabetes Mellitus; VLDL-C, very-low density lipoprotein cholesterol; HMGCoA, 3-hydroxy-3-methylglutaryl coenzyme A.
F. Zhubi-Bakija et al. / Clinical Nutrition xxx (xxxx) xxx 7protein intakes, 47 g/day were from animal protein source whereas
25 g/day from plant protein source. Total animal protein intakes
were mainly from meat and meat products (53%), whereas plant
protein intakes were from cereals and cereal products (54%). Fe-
males had lower animal and plant protein intakes compared with
males (p < 0.001). Legume and soya protein intakes were low in the
whole population (0.101 and 0.174 g/day, respectively). Animal
protein intake had positive correlation with BMI (b ¼ 0.013;
p ¼ 0.001) and WC (b ¼ 0.041; p ¼ 0.002) in male participants of
this study. In contrast, in participants of both genders, plant protein
intake was inversely associated with BMI (males: b ¼ 0.036;
p < 0.001; females: b ¼ 0.046; p ¼ 0.001) and WC (males:
b ¼ 0.137; p < 0.001; females: b ¼ 0.096; p ¼ 0.024). Based on
these findings, plant proteins could have important protective ef-
fect in general population in the prevention of overweight and
obesity [40].
Another study compared the effect of different diets (low-fat,
high carbohydrate [HC] and low-fat, high protein [HP] ad libitum
diets) on metabolic and CV risk factors in healthy obese subjects. In
addition, this study assessed the effect of these diets on weight
maintenance (WM) after weight loss (WL) induced by a very low-
calorie diet [41]. In the overweight and obese postmenopausal
women, the diet compound with low-fat, HP or HC did not reduce
BP, arterial stiffness or inflammatory markers during the 6 hPlease cite this article as: Zhubi-Bakija F et al., The impact of type of dietar
factors: A position paper from the International Lipid Expert Panel (ILEP)postprandially follow-up period, compared with the normal pro-
tein diet. During the WM period, participants received dietary
counselling from a dietician, maintaining the fat intake of approx-
imately 30% of total energy intake in all groups. In HC study group,
the participants had carbohydrate intake of at least 55% of total
energy intake, whereas the protein intake of at least 25% of energy
intake was in both HP groups. The participants of HC group
consumed also maltodextrin supplements twice a day (50 g/day),
whereas the HP group consumed intact casein or whey supple-
ments twice a day (50 g/day). The WM (2.3 kg difference, p ¼ 0.04)
and fat mass reduction (2.2 kg difference, p ¼ 0.02) were signifi-
cantly better in HP diet group compared with the HC group, after
their weight loss. TG and glucagon concentrations were increased
more in the HC diet group (0.6 mmol/L difference, p ¼ 0.01 and
9.6 pg/ml difference, p ¼ 0.02, respectively), while glucose con-
centration was increased more in the HP diet group (0.3 mmol/L
difference, p¼ 0.02) [41]. The authors concluded that low-fat, high-
casein or whey protein diets are more effective for WM after WL
compared with low-fat, HC diets and these diets do not adversely
affect metabolic and CV risk factors [41]. However, it is very difficult
finally to answer the question which component finally influenced
the weight in a causative way [41].
The postprandial effects of whey protein isolate on BP, vascular
function and inflammatory markers in overweight and obesey protein, animal versus vegetable, in modifying cardiometabolic risk
, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2020.05.017
Fig. 3. Meal replacement and its effect on cardiovascular disease (CVD) risk.
Fig. 4. Protein source pyramid.
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Table 4
Recommendations for dietary animal protein vs. plants protein.
Class Level Daily dose of types of proteins Effect on CV risk Cardiovascular effects
I B >50% plant protein/day of total protein intake Y BP, insulin resistance, weight, CV risk Y diastolic dysfunction
I B Reduction of red meat (100 kcal/day and 3 servings/week) Y BP, insulin resistance, obesity,
CHD, CV risk
Y diastolic dysfunction, [sICAM-1, sVCAM-1
Abbreviations: CV, cardiovascular; BP, blood pressure, CHD, coronary heart disease, sICAM-soluble intercellular adhesion molecule 1; sVCAM-soluble vascular adhesion
molecule 1.
F. Zhubi-Bakija et al. / Clinical Nutrition xxx (xxxx) xxx 9postmenopausal women were investigated by Pal et al. [42]. The
women included in the study consumed a breakfast, which
included 1 of 3 supplements: 45 g whey protein isolate, 45 g so-
dium caseinate or 45 g of a glucose control. It was shown that both
systolic and diastolic BP, and augmentation index (AIx) were
decreased initially after consumption of the meal, irrespective of
the supplement they receive, but these measurements gradually
returned to baseline levels after 6 h. Moreover, there were no sig-
nificant differences in the above measurements between the study
groups. These findings suggest that the effects will be better
observed from the long-term whey proteins consumption studies
[42]. In contrast, in another RCT the authors demonstrated that
different heart-healthy weight-loss dietary patterns with the ani-
mal and plant protein improved MetS indicators in a similar way
[43]. This study investigated the effects of 3 different diets with
different amounts of protein from plant and animal sources on
MetS indicators: (1) a modified-DASH (M-DASH) diet rich in plant
protein (18% protein, two-thirds plant sources), (2) M-DASH diet
rich in animal protein [Beef in an Optimal Lean Diet (BOLD): 18.4%
protein, two-thirds animal sources], and, (3) a moderate-protein
diet [Beef in an Optimal Lean Diet Plus Protein (BOLDþ): 27% pro-
tein, two-thirds animal sources]. These diets were compared at 3
phases of energy balance: (1) controlled WM, (2) controlled WL
with an exercise component, and (3) prescribed free-living (FL)
weight loss. All groups achieved about 5% weight loss and all study
groups MetS indices were improved irrespective of diet composi-
tion. MetS criteria were decreased after the WL phase [Healthy
American Diet (HAD) compared with WL, p < 0.01], and these
changes were maintained during the FL phase [Healthy American
Diet (HAD) compared with FL, p < 0.01]. In all study groups the
prevalence of MetS was 100% at the beginning of screening, but
dropped to 70% in the BOLD group, to 81% in the BOLD þ group and
to 90% M-DASH group after the HAD phase. After the WM phase,
the participants had a prevalence of MetS 80e90% [HAD vs WM,
p ¼ NS], which was decreased to 50e60% by WL and was main-
tained through FL (HAD, WM vs WL, FL, p < 0.01) [43].
A Chinese study showed that the replacement of standard-
protein diets (SP, 1.1 g protein/kg/day) with high-protein diets
(HP, 2.2 g protein/kg/day) in obese individuals with hyperlipidemiaTable 5
Recommendations for dietary intake and obesity.
Class Level Daily doses of dietary proteins
I A Plant proteins 25e43 g/day
III A Animal proteins 42 g/day
I A Standard protein diet (preferably plant-based) 0.8 g/
IIb B High protein diet (preferably plant-based) 1.4 g/kg/d
Abbreviations: BMI, body mass index, WC, waist circumference.
a It is not recommended for subjects with kidney diseases.
Please cite this article as: Zhubi-Bakija F et al., The impact of type of dietar
factors: A position paper from the International Lipid Expert Panel (ILEP)(TG > 1.7 and < 5.4 mmol/L) that were not under cholesterol-
lowering drug treatment did not affect WL and BMI reduction,
whereas the waist-hip ratio was decreased significantly in subjects
under HP diet compared with those with SP diet (0.03 ± 0.03
vs0.01 ± 0.04; p < 0.05) [44]. TGs decreased from baseline in both
groups, but this decrease did not differ between groups. This study
demonstrated that in patients with hyperlipidemia, a protein-
enriched meal replacement (MR) diet significantly reduce WC
compared with a standard protein diet [44] (Figs. 1e4, Table 5,
Suppl. Table 1).
4. Dietary protein intake and lipid disorders
Based on the current guidelines, the modification of CV risk
factors in general, and dyslipidemia particularly, by diet and life-
style is the basis of treatment [3,5]. Therefore, plant-based diets for
CVD prevention have attracted considerable interest. However, the
effect of plant protein and the specific substitution for animal
protein on blood lipids and prevention of CV disorders still remains
unclear, despite the opinion that this protein mediate the preven-
tion of dyslipidemia [45e47].
In a 12-week follow-up RCT, overweight women underwent a
hypocaloric diet [calculated-deficit diets (500 kcal/day)]. These
women were randomized to a beef-consumption or chicken-
consumption dietary group, in addition to a regular fitness
walking program. In both study groups theWLwas significant from
baseline to the end of the study (p < 0.05, for both), but did not
differ between groups (5.6 ± 0.6 kg, in the beef-consumption group
and 6.0 ± 0.5 kg in the chicken-consumption group) [48]. Body fat
percentage, TC and LDL-C was reduced significantly (p < 0.05 for
all), in both groups, with no significant differences between groups.
On the other hand, HDL-C did not change significantly in both
groups. Therefore, a high protein diet and exercise affect WL and
improve the lipid profile, irrespective of animal protein source [48].
A systematic reviewandmeta-analysis of RCTs performed by the
Nutrition Committee of the American Heart Association (AHA),
assessed the effect of animal protein substitutionwith plant protein
on LDL-C, non-HDL-C and ApoB [49]. The pooled data from 112 RCTs
(randomized, long-term, dietary intervention trials), showed thatThe effect on obesity Direct (cardio)vascular effect
YBMI, YBody weight,
YWaist circumference
Not demonstrated
[BMI, [Body weight,
[Waist circumference
Not demonstrated
kg/day YWC 6.78e8 cm
YBody weight
YBody fat %
Not demonstrated
aya YWC 3e5.22 cm
YBody weight
YBody fat %
Not demonstrated
y protein, animal versus vegetable, in modifying cardiometabolic risk
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F. Zhubi-Bakija et al. / Clinical Nutrition xxx (xxxx) xxx10substitution of animal protein with plant protein decreased LDL-C
by 0.16 mmol/L (6.2 mg/dl; p < 0.00001; I2 ¼ 55%), non-HDL-C by
0.18 mmol/L (7 mg/dl; 95%CI, 0.22 to 0.14 mmol/L; p < 0.00001;
I2 ¼ 52%), and ApoB by 0.05 g/L (95%CI, 0.06 to 0.03 g/L;
p < 0.00001; I2 ¼ 30%) [49].
Data from epidemiological studies suggest that soy consump-
tion may reduce the incidence of certain chronic diseases [5,50,51].
Furthermore, some clinical studies showed that ingestion of soy
proteins might reduce the CVD risk [5,50,51]. It was demonstrated
that soybeans contain other additional components, such as iso-
flavones, lecithins, saponins and fiber, which may improve CV
health and reduce CV risk factors through independent mecha-
nisms [5,50,51]. These datawere a reason that in 1999 U.S. Food and
Drug Administration (FDA) approved the food-labelling health
claim for soy proteins in the prevention of CHD [50,51]. Similarly, in
the United Kingdom, Brazil, South Africa, the Philippines, Indonesia,
Korea and Malaysia, the use of the soy proteins for the same in-
dications was also been approved thereafter. However, in different
studies the health benefits are variable and still inconsistent
[5,50,51].
The effect of soy protein on the lowering of cholesterol level in a
human study was reported for the first time in 1967, and demon-
strated that in men with hypercholesterolemia, the replacement of
mixed proteins mainly by isolated soy protein products at an intake
of 100 g/day reduced TC level by 2.59 mmol/L (100 mg/dl) [52]. A
meta-analysis of 30 studies published later suggested that the
mean intake of isolated or textured soy protein of 47 g/day (ranging
from 17 to 124 g/day) of isolated or textured soy protein resulted in
significant reduced TC by 9.3%, LDL-C by 12.9%, and TG by 10.5%,
compared with animal protein intake. Based on this data the FDA
approved a food-labelling health claim for soy protein in the pre-
vention of CHD [53]. In addition, the AHA has acknowledged the
data regarding the efficacy of soy protein in CVD risk factors
reduction as still limited and insufficient [51]. In a study that
randomly compared diets with milk protein (Milk), isoflavone-poor
soy (Soy-), or isoflavone-rich soy (Soyþ), it was demonstrated that
the soy-consumption increases the postprandial triacylglycerol
(TAG), suggesting that the absence of isoflavones in soy proteinmay
have adverse effects on cardiometabolic risk factors [51]. The usual
diets in these study participants were supplemented for 28 days
with 25 g/day of protein. In addition to baseline measurements of
TAG and other cardiometabolic parameters, they were additionally
measured after supplementation in a fasted state and postprandi-
ally at 30, 60, 120, 240, and 360min after a high fat 1000 kcal shake.
Postprandial TAG increased after Soy-consumption in participants,
suggesting that the postprandial state is a more sensitive indicator
of soy ingestion effects on CVD risk factors compared with the
fasting lipid profile [51].
The Nutrition Committee of AHA published the pooled data
from 22 RCT that analyzed dietary effects of isolated soy protein in
comparison with casein protein, wheat protein and mixed animal
proteins [54]. The range of soy protein used in these RCTs was from
25 to 135 g/day, whereas the range of isoflavones was from 40 to
318 mg/day. The meta-analysis showed that LDL-C or non-HDL-C
concentrations were significantly decreased by soy protein intake
[54]. In a study that included 60 postmenopausal hypertensive
women, who were followed for 8 weeks, daily supplementation of
25 g of soy protein and 101mg of aglycone isoflavones reduced LDL-
C and ApoB levels by 11% and 8%, respectively, and reduced systolic
and diastolic BP by 9.9% and 6.8%, respectively [55].
For the initial treatment of hypercholesterolemia, the National
Cholesterol Educational Program (NCEP) step I diet is usually rec-
ommended, which consist in the restriction of fat and cholesterol
intake [56]. In a randomized crossover study, normocholester-
olemic and hypercholesterolemicmen consumed either NCEP step IPlease cite this article as: Zhubi-Bakija F et al., The impact of type of dietar
factors: A position paper from the International Lipid Expert Panel (ILEPsoy protein diet or an NCEP step I animal protein diet for 5 weeks, to
evaluate the possible hypocholesterolemic effect of the soy protein.
Regardless of plasma lipid status, the soy-protein diet significantly
decreased plasma concentrations of LDL-C for approximately 6%
(p ¼ 0.029) and plasma LDL-C to HDL-C ratio by 11% (p ¼ 0.005).
This study concluded that the NCEP step I soy protein diet enhances
the hypocholesterolemic effect in both normocholesterolemic and
hypercholesterolemic men [56].
Whether intact of milk proteins lowers 24 h ambulatory BP and
other risk factors of CVD was investigated in a double-blinded,
randomized, 3 way-crossover intervention study [57]. Participants
randomly consumed 28 g whey protein 2 times/day, 28 g calcium-
caseinate, or 27 g maltodextrin (as a control group) for 8 weeks
with a 4-week washout period. Besides significant reductions in
SBP and DBP, as well as the peripheral, central systolic, and mean
pressures after whey-protein supplementation compared with
controls, the authors also noted significant changes in lipids. Both
whey-protein and calcium-caseinate intakes increased FMD (1.31%;
p < 0.001, and 0.83%; p ¼ 0.003, respectively), lowered TC
[0.26 mmol/L (p ¼ 0.013) and 0.20 mmol/L (p ¼ 0.042),
respectively], but only whey protein decreased TG (0.23 mmol/L;
p ¼ 0.025) compared with controls. The soluble intercellular
adhesion molecule 1 and soluble vascular cell adhesion molecule 1
were also reduced by both whey protein and calcium-caseinate
consumption (p ¼ 0.011 and p ¼ 0.039, respectively) compared
with controls. In conclusion, unhydrolyzed milk proteins con-
sumption (56 g/d) for 8 week improved vascular reactivity, endo-
thelial function and lipid risk factors, whereas whey-protein
supplementation lowered both systolic and diastolic BP [57].
A crossover RCT [58] studied the effect of diet with increased
protein intake (HP), at the expense of carbohydrates, in healthy
humans consuming a high fat, hypercaloric diet. The effect of this
diet was observed on intrahepatic lipids (IHLs), circulating TGs, and
it was indicated that HP, high fat, hypercaloric diet significantly
affects lipid metabolism. After a 2-week run-in period, participants
were randomized to: (1) the control diet [(27.8 energy % [en%] fat,
16.9 en% protein, 55.3 en% carbohydrates)] for 4 weeks, or, (2) the
high-fat, hypercaloric diet (>2 MJ/day). The crossover trial was
designed with 2 periods of 2 weeks, with either HP (37.7 en% fat,
25.7 en% protein, 36.6 en% carbohydrates) or SP (39.4 en% fat, 15.4
en% protein, 45.2 en% carbohydrates) diets. A trend toward lower
intrahepatic lipids (IHL) and plasma TG concentrations during the
HP condition compared with the SP condition was observed (IHL:
0.35 ± 0.04 vs 0.51 ± 0.08%, p ¼ 0.08; TG: 0.65 ± 0.03 vs
0.77 ± 0.05mmol/L, p¼ 0.07, for HP and SP, respectively). On the HP
diet the fat mass was lower (10.6 ± 1.72 vs 10.9 ± 1.73 kg; p ¼ 0.02),
whereas fat-free mass was higher (55.7 ± 2.79 vs 55.2 ± 2.80 kg;
p ¼ 0.003), compared with the SP diet. This study found that a HP,
high fat, and hypercaloric diets affect the lipid metabolism. This
diet lowers fat mass and increases fat-free mass and tends to lower
the IHL and circulating TG concentrations compared with an SP,
high fat, hypercaloric diet [58].
In a RCT, healthy overweight women, in addition to the regular
aerobic clubs exercise, received a HP diet during an 8-week
investigation (45% of energy from carbohydrates, 25% from pro-
teins, and 30% fat) or balanced diets (BDs; carbohydrates 55%,
proteins 15%, and fat 30%). It was shown that in these overweight
and obese women with regular aerobic exercise lipid profiles and
hsCRP levels were improved after administration of both HP and
BD, irrespective of the type of diet. Concentrations of LDL-C
(p < 0.001 in the BD group vs p ¼ 0.023 in the HP group) and
HDL-C (p < 0.001 in BD group vs p ¼ 0.002 in the HP group) were
improved significantly in both groups. Circulating TGs levels
improved in both interventions groups, but the change in the HP
group was not significant (p¼ 0.007 in BD group vs p¼ 0.099 in they protein, animal versus vegetable, in modifying cardiometabolic risk
), Clinical Nutrition, https://doi.org/10.1016/j.clnu.2020.05.017
F. Zhubi-Bakija et al. / Clinical Nutrition xxx (xxxx) xxx 11HP group), whereas TC concentration decreased, however without
significant differences (p ¼ 0.53 in BD group vs p ¼ 0.73 in the HP
group). There were marginally significant decreases in the hsCRP
levels due to both diets (p ¼ 0.057 in the BD group vs p ¼ 0.086 in
the HP group) [59].
In a randomized crossover study [60], the effects of diets high in
vegetable protein (specifically, wheat gluten) on lipids, uric acid
and renal functionwas investigated. In subjects with HP diet, 11% of
the total dietary energy from starch in the control bread was
replaced by vegetable protein (wheat gluten). The diets differ be-
tween groups only regarding the percentage of protein within total
energy; 27% in HP group compared to 16% in the control group. The
HP diet resulted in lower triacylglycerol, uric acid and creatinine
concentrations compared with controls (by 19.2 ± 5.6%; p ¼ 0.003,
by 12.7 ± 2.0%; p < 0.001 and by 2.5 ± 1.1%; p¼ 0.035, respectively),
whereas urea and 24-h urinary urea output had higher concen-
trations (by 42.2 ± 5.8%; p < 0.001 and by 99.2 ± 17.2%; p < 0.001,
respectively). TC, HDL-C and the renal clearance of creatinine did
not differ significantly between groups [60].
In a 12-weeks RCT diet intervention study, the effect of dietary
supplementation with whey protein and medium chained SFA
(MC-SFA) on postprandial lipid metabolism in subjects with
abdominal obesity was investigated [61]. The diet contained 60 g
milk protein (whey or casein) and 63 g milk fat, with high or low
MC-SFA content daily. It was found that the postprandial ApoB-48
(as a specific marker for chylomicrons of intestinal origin)
response decreased significantly after whey consumption by
4310 mg/L (95%CI: 559e8060) compared with casein consumption
(p ¼ 0.025) independently of fatty acid composition. Furthermore,
supplementation with casein increased postprandial glucagon-like
peptide 1 (GLP-1) response compared with supplementation with
whey (p ¼ 0.003). However, no interactions of milk protein and
milk fat with postprandial lipidemia were observed. The authors
concluded that in subjects with abdominal obesity, a whey protein
supplement decreases the postprandial chylomicron response
compared with casein supplementation, thereby indicating that
whey protein may have a beneficial impact on CVD risk [61].
An interest in the effect of nutraceuticals on improvement and
optimization of dyslipidemia control and treatment was introduced
in recent years [62]. It was shown that some nutraceuticals have
lipid-lowering properties and possible positive effects on non-lipid
CV risk factors, improving markers of vascular dysfunction (e.g.
endothelial function and pulse wave velocity). The lipid-lowering
activity in hypercholesterolemic patients of plant proteins (lupin
protein or pea protein) associated with soluble fibers (oat fiber or
apple pectin), who received these nutraceuticals for primary pre-
vention of CVD, was confirmed: TC were decreased in all groups,
particularly in patients that had diet with lupin protein þ cellulose
(0.3 mmol/l (11.6 mg/dl), 4.2%), casein þ apple pectin
(0.39 mmol/l (15 mg/dl), 5.3%), pea protein þ oat fiber
(0.35 mmol/l (13.5 mg/dl), 4.7%) and pea protein þ apple pectin
(0.43mmol/l (16.6mg/dl),6.4%) (p< 0.05). Moreover, LDL-Cwas
significantly reduced in subjects that had diet with pea
protein þ apple pectin combinations (0.27 mmol/l (10.4 mg/dl),
9.2%) (p < 0.004 vs controls) [62,63] (Figs. 1e4, Table 6,
Suppl. Table 1).Table 6
Recommendations for dietary protein intake and lipid disorders.
Class Level Plant protein Effects
on LDL-C
I A 15e52 g/day plant proteins 12 to 20
Abbreviations: LDL-C, low density lipoprotein cholesterol, HDL-C, high density lipoprot
Please cite this article as: Zhubi-Bakija F et al., The impact of type of dietar
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Hypertension remains the leading cause of morbidity and
mortality worldwide [1], being a key risk factor of heart disease,
stroke and kidney failure [1,4]. Genetic and lifestyle factors have
important roles in the development of hypertension. It is known
that reducing carbohydrates and salt intake can help to lower BP,
but also adequate protein intake may attenuate hypertension [1]. A
significant inverse association between protein intake and BP, was
documented in several RCTs and observational studies [1,64e66].
Moreover, some animal and human studies have shown that some
amino acids may have antihypertensive effects. It was shown that
glutamate, cysteine, glutathione and arginine may attenuate and
prevent alterations that cause hypertension, including increased
insulin resistance, increased oxidative stress, decreased NO
bioavailability, and altered renin angiotensin system function
[1,11,12]. While, leucine enhanced protein synthesis in skeletal
muscle and improved insulin resistance, taurine and tryptophan
attenuated the activity of sympathetic nervous system, whereas
soy protein lowered BP through its high arginine content and
antioxidant activity by isoflavones [1,11,12].
A diet containing an ample amount of protein per day may be
beneficial for individuals with hypertension, serving as a part of
lifestyle changes in these patients. The Dietary Approaches to Stop
Hypertension (DASH) diet, includes high amount of vegetables,
fruits, whole cereal products and low-fat dairy products; low in
salt and saturated fat; moderately high in protein; and includes
whole grains, poultry, fish and nuts [64]. This diet lowered BP
more than typical North American diet [54], even after modifi-
cations made to have both diets lower and similar sodium con-
tents in DASH study [64].
The Optimal Macronutrient Intake Trial to Prevent Heart Disease
(OmniHeart) trial studied 3 diet patterns that differed in macro-
nutrient composition: (1) the diet rich in carbohydrates (58% car-
bohydrate, 15% protein, and 27% fat), (2) HP diet (48% carbohydrate,
25% protein, and 27% fat), and (3) the diet with higher unsaturated
fat (48% carbohydrate, 15% protein, and 37% fat) [65]. The results of
this trial showed that among those with hypertension, the protein
diet decreased mean SBP by 3.5 mmHg (p ¼ 0.006), LDL-C by
3.3 mg/dl (0.09 mmol/L; p ¼ 0.01), HDL-C by 1.3 mg/dl (0.03 mmol/
L; p ¼ 0.02) and TGs by 15.7 mg/dl (0.18 mmol/L; p < 0.001),
compared with the carbohydrate diet. On the other hand, the un-
saturated fat diet among those with hypertension decreased SBP by
2.9 mmHg (p ¼ 0.02), increased HDL-C by 1.1 mg/dl (0.03 mmol/L;
p ¼ 0.03) and lowered TGs by 9.6 mg/dl (0.11 mmol/L; p ¼ 0.02),
compared with the carbohydrate diet. This diet had no significant
effect on LDL-C. Moreover, compared with the carbohydrate diet,
the estimated 10-year CHD risk was lower and similar on the pro-
tein and unsaturated fat diets [65]. The results from most relevant
studies that investigated the effect of dietary protein on BP,
including the OmniHeart [65], International Study of Salt and Blood
Pressure (INTERSALT) [60] and DASH studies [64] demonstrated an
inverse relationship between dietary protein and BP. The nones-
sential amino acid cysteine, as a component of dietary protein, was
introduced as in important amino acid for its antihypertensive ef-
fects. Studies have shown that N-acetylcysteine, a stable cysteineEffects on Effects Direct vascular
non-HDL-C on Apo-B effect
% 14 to 22% 3 to 6% Not demonstrated
ein cholesterol, ApoB, apolipoprotein B.
y protein, animal versus vegetable, in modifying cardiometabolic risk
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hypertension [12]. The possible mechanisms of the antihyperten-
sive effects of cysteine are through decreasing oxidative stress,
lowering advanced glycation end products, improving insulin
resistance (IR) and glucosemetabolism, and bymodulating levels of
NO and other vasoactive molecules. Therefore, a balanced diet
containing cysteine-rich proteins was proposed as a beneficial
lifestyle choice for patients with hypertension [12].
It was documented that the diet rich in protein that contains the
semi-essential amino acid arginine, lowers BP in humans and in
animal models [11]. The possible mechanism of the lowering BP is
through improvement of endothelial cell function and decreasing
peripheral vascular resistance, due to the ability of arginine to
decrease insulin resistance, to decrease glycation end products
formation, to increase NO production, and decrease angiotensin II
levels and oxidative stress [11]. The DASH study demonstrated that
the DASH diet, which is rich in protein, lowered BP more than a
typical North American diet with similar reduced sodium content.
The mechanism of the BP lowering by DASH diet may be addressed
to its higher arginine-containing protein, higher antioxidants and
low salt content [11].
The INTERMAP study, which included 4680 men and women,
aged 40e59 years, from 17 randomly selected population samples
in Japan, China, United Kingdom and United States assessed the
relationship of animal, plant and total protein intake to BP, by
measuring their BP 8 times at 4 visits. Significant inverse rela-
tionship between vegetable protein intake and BP was registered
[66] - higher vegetable protein intake by 2.80% kilocalories (i.e. 2 SD
of vegetable protein intake) was associated with 2.72 mmHg
lowering of SBP and 1.67 mmHg of DBP. When these values were
adjusted for height and weight, there were 1.95 mmHg for SBP
and 1.22 mmHg for DBP (p < 0.001 for both). Patients with high
vegetable and low animal protein intake diets had different amino
acid contents compared with subjects with low vegetable and high
animal protein intake diets. The BP was registered in individuals
from the country-specific top quartiles of vegetable protein intake
and bottom quartiles of animal protein intake (who consumed 9.1%
of their total calories from vegetable protein and 4.3% from animal
protein), and in individuals from the country-specific bottom
quartiles of vegetable protein intake and top quartiles of animal
protein intake (who consumed 5.4% of their total calories from
vegetable protein and 12.0% from animal protein). The individuals
from the country-specific top quartiles of vegetable protein intake
and bottom quartiles of animal protein intake had lower BP
adjusted for sample, age and sex (4.15 mmHg for SBP, p < 0.001
and 2.15 mmHg for DBP, p < 0.01). Based on these findings, a diet
high in vegetable products, as a part of healthy lifestyle for pre-
vention of high BP and related diseases, was recommended [66].
The INTERSALT cross-sectional multicentre study, performed in
32 countries worldwide, evaluated the impact of dietary protein in
BP, by measuring 3 dietary protein parameters in 24 h urine all
study included participants: nitrogen and urea, which were used as
indexes of total protein intake, and sulfate, which was used as an
index of sulphur-containing dietary amino acids [67]. Both 24 h
urinary total nitrogen and urea nitrogen had significant indepen-
dent inverse relationship with systolic and diastolic BP. SBP and
DBP were 3.0 and 2.5 mmHg lower, respectively, in subjects who
had dietary total protein intake 30% above the overall mean
compared with subjects who had dietary protein intake 30% below
the overall mean, supporting the hypothesis that higher dietary
protein intake has favourable influences on BP [67]. A Japanese
cross sectional study with >7500 subjects aged from 40 to 69 years
showed that an increment by 25.5 g/day in total protein intake
decreased SBP for 1.14 mmHg (p < 0.001) and DBP for 0.65 mmHg
(p < 0.001), an increment by 19.9 g/day in animal protein intakePlease cite this article as: Zhubi-Bakija F et al., The impact of type of dietar
factors: A position paper from the International Lipid Expert Panel (ILEPdecreased SBP for 1.09 mmHg (p < 0.001) and DBP for 0.41 mmHg
(p ¼ 0.003) and an increment by 13.1 g/day in plant protein intake
reduce only DBP by 0.57 mmHg (p < 0.001) [68]. The Isfahan
Healthy Heart Program [69] evaluated the effect of different protein
intake diets on BP in 9660 randomly selected Iranian adults and
found that more frequent total, animal and plant protein intakewas
significantly related to lower SBP and DBP in a crude model
(p < 0.001); however, after adjusting for potential confounders in
the fully-multivariable adjusted model, only more frequent plant
protein consumption was significantly associated with lower SBP
and DBP (p ¼ 0.04). The ORs (95%CI) of crude and multivariate
adjustedmodels revealed a greater risk of HTN for participants with
less frequent total protein intake (OR ¼ 0.43; 0.36e0.51; p-for-
trend<0.001). All multivariate adjusted models demonstrated sig-
nificant inverse relationships between higher category of total
protein consumption and risk of HTN, which was decreased 19% in
subjects with the highest quintile of total protein consumption in
fully adjusted model (0.81 [0.65e0.96]; p-for-trend ¼ 0.004). Ani-
mal protein consumption had a marked effect in lowering the risk
of HTN (0.59; 0.50e0.70; p-for-trend<0.001 only in a crude model).
The lower risk of HTN occurrence was associated with more
frequent consumption of plant protein in crude and fully adjusted
models. ORs demonstrated that the highest quintile of plant protein
intake was related to 60% reduction in the occurrence of HTN (0.40
[0.34e0.48]; p < 0.001). ORs attenuated marginally by excluding all
potential confounder effects (0.82 [0.67e0.94]; p ¼ 0.03). The au-
thors concluded that more frequent protein intake, particularly
plant protein, was inversely associated with BP and risk of HTN
development among Iranian adults [69].
The PREMIER study [21] had similar results to the above studies
where plant proteins where inversely linked with systolic and
diastolic BP during the 6- and 18-months follow-up period, irre-
spective of change in body weight and WC. This study demon-
strated a strong inverse association of plant protein intake with
both systolic (p ¼ 0.0045) and diastolic BP (p ¼ 0.0096) after
adjusting for all covariates and other intakes (fat, fibre, calcium and
potassium). Fruit/vegetable intake was also had significant inverse
association with systolic BP (p ¼ 0.0003) and diastolic BP
(p ¼ 0.0157) after adjusting for all covariates and other intakes
(dairy, meat and fat) at 6 months. On the other hand, the 6 months
changes in plant protein intake were inversely associated with
changes in systolic BP (p ¼ 0.0486), but there were not significant
changes in diastolic BP (p ¼ 0.0759). The odds of having hyper-
tensionwere lowered for 25% with every 1-unit (% of kcal) added in
dietary plant protein intake (OR ¼ 0.75; 95%CI: 0.60, 0.95). In
addition, every extra serving of fruit/vegetable, the decreased the
odds of having HTN by about 23% (OR ¼ 0.77; 95%CI: 0.79, 0.97)
[21].
In the ChicagoWestern Electric Study [70], which included 1700
middle-aged employed men followed for 8 years, systolic and
diastolic BP had inverse correlation with vegetable protein intake
and positive correlation with animal protein intake and total pro-
tein intake. In men who consumed 14e42 cups of vegetables a
month (0.5e1.5 cups/day) the SBP was increased for 2.8 mmHg less
than in thosewho consumed<14 cups amonth (<0.5 cups/day) in 7
years (p < 0.01). On the other hand, men who consumed 14e42
cups of fruit a month the SBP was increased for 2.2 mmHg less than
in those who consumed <14 cups a month in 7 years (p < 0.05).
Moreover, there was observed a direct relationship between beef-
veal-lamb and poultry intakes with the SBP/DBP increase
(p < 0.05). The results of this study support the concept that the risk
of developing high BP may be reduced with diets higher in fruits
and vegetables and lower in meats (except fish) [70].
Data from epidemiological studies suggest that, in populations
who consume large amounts of soy protein, the incidence of CHD isy protein, animal versus vegetable, in modifying cardiometabolic risk
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decreased oxidative stress and improved endothelial function,
reducing BP in vivo in rats. The mechanism of this vascular reac-
tivity improvement was considered to be through increased mito-
chondrial glutathione andmRNA levels for endothelial NO synthase
(eNOS). It is considered that the reduced eNOS and antioxidant
gene expression, impaired endothelial function, and elevated BP in
animals fed a soy-deficient diet, which was reversed with re-
feeding rats with an SP diet for the period of 6 months [71]. The
findings of this study suggest that an SP diet reduce oxidative stress
and increases NO bioavailability, through eNOS and antioxidant
gene expression in the vasculature and other tissues. These effects
cause lowering of BP, considering soy isoflavones as an alternative
therapy for BP lowering and control, particularly in post-
menopausal women and patients at risk of CHD [71]. In contrast,
Teede et al. conducted a double-blind, placebo controlled cross-
over trial where 40 subjects received soy cereal (40 g soy protein,
118 mg isoflavones) and gluten placebo cereal, each for 3 months
[72]. Subjects that had soy protein diet had a higher 24 h systolic BP
by 2.3 mmHg (p ¼ 0.003), a higher daytime systolic BP by
3.4 mmHg (p ¼ 0.0002) and a higher daytime diastolic BP by
1.4 mmHg, compared with subjects that had gluten protein diet
(p ¼ 0.008). However, there was not observed significant difference
between diet groups in overall 24 h diastolic BP, night systolic BP
and night diastolic BP. Furthermore, subjects with soy protein diet
had higher 24 h heart rates by 3.5 bpm (p < 0.0001) compared with
gluten protein diet [72].
The Shanghai Women's Health Study examined the association
of usual soy foods intake and BP in 45,694 participants of,
measuring BB at baseline and after 2e3 years of this diet [73]. Soy
protein intake had inverse correlation with both systolic BP (p-for-
trend ¼ 0.01) and diastolic BP (p-for-trend ¼ 0.009) after adjusting
for age, BMI, lifestyle and other dietary factors. The adjusted mean
systolic and diastolic BP were for 1.9 mmHg and for 0.9 mmHg
lower, respectively, in women who consumed 25 g soya protein/
d than inwomen consuming <2.5 g/day. These associations became
stronger with increasing age (p for interaction <0.05 for both BPs)
[73]. Among women >60 years old, the corresponding differences
were 4.9 mmHg (95%CI: 8.0, 1.9 mm Hg) for systolic BP
and 2.2 mmHg (95%CI: 3.8, 0.6 mmHg) for diastolic BP [73].
Similar results were achieved in another RCT, conducted by He
et al., where 40 g/day of soya bean protein were given to 302 par-
ticipants with an initial untreated systolic BP of 130e159 mmHg,
diastolic BP of 80e99 mmHg, or both [74]. After the 12-week
intervention, the net changes in SBP and DBP were 4.31 mmHg
(95%CI, 2.11 to 6.51 mmHg; p < 0.001) and 2.76 mmHg (95%
CI, 1.35 to 4.16 mmHg; p < 0.001), respectively. The net changes
in systolic and diastolic BP reductions were 7.88 mmHg (95%
CI, 4.66 to 11.1 mmHg) and 5.27 mmHg (95%CI, 3.05
to 7.49 mmHg), respectively, in persons with hypertension
and 2.34 mmHg (95%CI, 0.48 to 5.17 mmHg) and 1.28 mmHg
(95%CI, 0.52 to 3.07 mmHg), respectively, in those without hy-
pertension [74]. A meta-analysis of 27 RCTs that examined the ef-
fects of soya protein on BP showed participants in the soya protein
group had a mean decrease of 2.21 mmHg (95%CI 24.10, 20.33;
p ¼ 0.021) for SBP and 1.44 mmHg (95%CI 22.56, 20.31; p ¼ 0.012)
for DBP, compared with controls. Soya protein consumption
reduced SBP and DBP in both hypertensive and normotensive
subjects, but these reductions were markedly greater in hyper-
tensive subjects [75].
Another double-blinded, 3-way-crossover, RCT concluded that
intact milk proteins, particularly whey protein, decrease 24 h
ambulatory BP and other risk markers of CVD [57]. The study found
that after whey-protein supplementation (2  28 g/day) compared
with control intake (2  27 g maltodextrin (control)/day),Please cite this article as: Zhubi-Bakija F et al., The impact of type of dietar
factors: A position paper from the International Lipid Expert Panel (ILEP)significant reductions in 24-h BP [SBP: 3.9 mmHg; for
DBP: 2.5 mmHg; p ¼ 0.050 (for both)] were observed. Peripheral,
central and mean systolic pressures [-5.7 mmHg
(p ¼ 0.007), 5.4 mmHg (p ¼ 0.012), and 4.0 mmHg (p ¼ 0.019),
respectively] were also lowered by whey-protein supplementation
compared with controls [57]. FMD was increased after both whey-
protein and calcium-caseinate intakes (2  28 g calcium caseinate/
day) compared with control intake [1.31 and 0.83%, respectively].
TC was lowered by both whey protein and calcium caseinate
[for0.26 and0.20mmol/L, respectively], whereas triacylglycerol
was decreased (for0.23 mmol/L) only by whey protein, compared
with controls. In conclusion, this study found that unhydrolyzed
milk proteins consumption (56 g/day, for 8 weeks) affected bio-
markers of endothelial function and lipid risk factors, and also
improved vascular reactivity. Therefore, the 24 h ambulatory SBP
and DBP were lowered by whey-protein supplementation [57].
Apart from the studies that showed the inverse association
between BP and dairy consumption, there is few data on the
postprandial effects of milk proteins on BP [76]. The lunch diet with
28 g whey protein was compared with diet of 28 g calcium-
caseinate or 27 g maltodextrin effect in adults there were taking
of a high fat, isoenergetic breakfast and the outcomes on BP and
other CVD risk factors were observed. Up to 5 h post-ingestion, the
whey protein significantly reduced systolic BP compared with
calcium-caseinate (15.2 ± 13.6 mmHg) and maltodextrin
(23.4 ± 10.5 mmHg). In addition, the arterial stiffness was
improved by whey protein compared to maltodextrin (incremental
Area Under the Curve-iAUC0e8h: þ14.4 ± 6.2%) [76]. The insulin
response was higher in subjects with whey protein diet compared
with those on a calcium-caseinate diet
(iAUC0e8h: þ219.5 ± 54.6 pmol/L), despite similar glucose levels in
both diet groups. The suppression of non-esterified fatty acids was
induced less in subjects who received calcium-caseinate than those
with whey protein (iAUC0e5h: 58.9 ± 135.5 mmol/L) and malto-
dextrin (iAUC0e5h: 106.9 ± 89.4 mmol/L). In these subjects,
calcium-caseinate induced also a smaller postprandial tri-
acylglycerol response than in subjects with whey protein
(iAUC0e8h: 1.68 ± 0.6 mmol/L). The authors concluded that milk
proteins might have beneficial effect on the maintaining and
improvement of CVD risk factors [76].
In overweight and obese postmenopausal women, a breakfast
meal with 1 of 3 supplements: 45 g whey protein isolate, 45 g so-
dium caseinate or 45 g of a glucose control, lowered both SBP and
DBP, and decreased AIx decreased initially, irrespective from the
supplement they receive, but these changes returned to baseline
levels by 6 h [77]. These different supplements also did not have
different effects on plasma inflammatory markers (IL-6, TNF-a and
CRP). This study concluded that the beneficial effects on BP,
vascular function or inflammatory markers previously seen with
chronic whey protein ingestion were not seen in the acute post-
prandial period, suggesting long-term consumption of whey pro-
teins [77].
Another randomized study compared the effects of whey pro-
tein with casein supplementation, using glucose supplementation
as control group, on BP, vascular function and inflammatory
markers in overweight/obese individuals [78]. The SBP was
decreased significantly at week 6 in the whey and casein groups,
(p ¼ 0.028 and p ¼ 0.020, respectively) and at week 12 (p ¼ 0.020,
and p ¼ 0.017, respectively) compared with baseline. On the other
hand, whey and casein decreased DBP at 12 weeks compared with
baseline (p ¼ 0.038 and p ¼ 0.042, respectively), and compared
with controls (p ¼ 0.025, p ¼ 0.038, respectively). The whey sup-
plement also lowered AIx 12 weeks (p ¼ 0.021) compared with
baseline and compared with controls (p ¼ 0.006) and casein
(p ¼ 0.006). There changes of inflammatory markers did not differy protein, animal versus vegetable, in modifying cardiometabolic risk
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Table 7
Recommendations for dietary protein intake and hypertension.
Class Level Daily dose of Dietary protein Effect on SBP Effect on DBP Vascular effect
IIa A 20e50 g/day (soy protein) 1.28 to 17.0 mmHg 0.9 to 12.2 mmHg [NO, improve systemic arterial compliance, contains
ACE inhibitory peptides.
IIa A 28e70 g/day (whey protein) 3.8 to 15.2 mmHg 2.1 to 2.5 mmHg [Flow mediated dilatation
YAugmentation Index
Abbreviations: SBP, systolic blood pressure, DBP, diastolic blood pressure, NO, nitric oxide, ACE, angiotensin converting enzyme.
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protein improves BP and vascular function in overweight and obese
subjects [78] (Figs. 1e4, Table 7, Suppl. Table 1).
6. Dietary protein intake and diabetes mellitus (DM)
DM is one of the most common endocrine diseases worldwide,
and also the most important conventional risk factor of CVD, which
prevalence was increased in adults from 4.7% in 1980 to 8.5% in
2014 [79]. DM is also a major cause of myocardial infarction, stroke,
chronic kidney failure, blindness and lower limb amputation [79].
Mirmiran et al. [80] analyzed the associations of total protein
intake and the animal-to-plant (A/P) protein ratio with cardio-
metabolic risk factors. BMI correlated with total protein intake in
men (b ¼ 0.14, p ¼ 0.01) and A/P protein ratio inwomen (b ¼ 0.075,
p ¼ 0.01), whereas WC correlated with total protein intake
(b ¼ 0.048, p ¼ 0.03) and A/P protein ratio (b ¼ 0.031, p ¼ 0.05) in
women. On the other hand, the fasting glucose was associated with
both total protein intake (b ¼ 0.061 and 0.11, p < 0.05) and the A/P
protein ratio (b ¼ 0.078 and 0.056, p < 0.05) in both men and
women, respectively. The total protein intake was associated with
serum HDL-C (b ¼ 0.107 and 0.07, p < 0.05) in both men and
women, and with DBP in women (b ¼ 0.125, p ¼ 0.01). The con-
clusions of this study were the higher dietary protein intake asso-
ciate with enhanced HDL-C levels, WC, and DBP, and a higher A/P
protein ratio was associated with lower serum fasting glucose and
WC [80].
In addition to obesity, which is considered the most important
risk factor for type 2 DM (T2DM), the certain foods and dietary
factors are shown to be associated with DM [81]. A prospective
study of 69,554 women aged 38e63 years without a history of DM,
CVD or cancer, the associations between twomajor dietary patterns
(Prudent” and “Western”) and risk of T2DM was assessed [81]. The
prudent pattern is characterized by higher intakes of fruits, vege-
tables, fish, legumes, poultry and whole grains, while the Western
pattern contained higher intakes of meats (red and processed),
sweets, desserts and refined grains. The highest quartile of Western
pattern had higher relative risk (RR) for DM by 1.49 (95%CI,
1.26e1.76, p for trend <0.001) compared to its lowest quintile. The
read and processed meats intake also had a positive association
with T2DM. One-serving of red meat and of processed meat
increased RR for T2DM by 1.26 (95%CI, 1.21e1.42) and 1.38 (95%CI,
1.23e1.56), respectively. This increased RR for T2DM was increased
also for bacon and hot dog intakes, by 1.73 (95%CI, 1.39e2.16) and
1.49 (95% CI, 1.04e2.11), respectively [81]. In conclusion, the
Western pattern of diet (high in red and processed meats, refined
grains, sweets and deserts) elevates risk of T2DM development in
women. Therefore, it is recommended to reduce the consumption
of these food items to decrease the risk of T2DM [81].
The prospective EPIC-InterAct case-cohort study, which inves-
tigated the association of protein intake with T2DM incidence [82],
found that high total and animal protein intake is associated with a
modestly elevated risk of T2DM in European adults. In this contest,
limiting iso-energetic diets high in dietary proteins, particularly
those from animal sources, should be considered [82]. A studyPlease cite this article as: Zhubi-Bakija F et al., The impact of type of dietar
factors: A position paper from the International Lipid Expert Panel (ILEPwhich involved 6822 participants aged 45 years without DM,
found a significant association of higher animal protein intake
(frommeat, dairy and fish food sources) increased IR and increased
risk of pre-DM and T2DM, which are partly mediated by obesity
over time [83]. Higher total protein intake was associated with
increased longitudinal homeostatic model assessment of IR
(HOMA-IR) and with increased risk of pre-diabetes and T2DM. The
association of total animal protein with HOMA-IR was 0.10 (0.07,
0.12), and that for prediabetes was 1.35 (1.24, 1.45), whereas T2DM
was 1.37 (1.26; 1.49). The harmful associations of total animal
protein were contributed to by protein from meat, fish, and dairy
(e.g. for HOMA-IR: protein from meat, 0.13 (0.10, 0.17); from fish,
0.08 (0.03, 0.13); from dairy, 0.04 (0.0003, 0.08)) [83]. On the other
hand, the total plant protein, proteins from legumes and nuts, those
from grains, potatoes, or from fruits and vegetables did not asso-
ciate with any of the outcomes. Furthermore, plant protein from
legumes and nuts, from grains, from potatoes, or from fruits and
vegetables of different sources did not correlate with insulin
resistance, and risk of pre-DM and T2DM. The findings of this study
highlight the role of specific protein from different food sources,
particularly high animal protein intake, which may be harmful in
the development of T2DM even already in early stages [83].
Over an average of 8.8 years, 37,309 participants in theWomen's
Health Study aged 45 years were prospectively assessed for the
effect of red meat intake at the incidence of T2DM [84], and the
positive associations between red and processed meat intake and
the risk development of T2DM were found. Women in the highest
quintile of red and processed meat intake had higher multivariate-
adjusted RRs of T2DM by 1.28 (95%CI 1.07e1.53, p < 0.001 for trend)
and 1.23 (1.05e1.45, p ¼ 0.001 for trend), respectively, compared
with those in the lowest quintile of red and processed meat intake.
Furthermore, the frequent consumption of total processed meat
(RR 1.43, 95%CI 1.17e1.75 for 5/week vs < 1/month, p < 0.001 for
trend) and 2 major subtypes, which were bacon (1.21, 1.06e1.39 for
2/week vs < 1/week, p ¼ 0.004 for trend) and hot dogs (1.28,
1.09e1.50 for 2/week vs < 1/week, p ¼ 0.003 for trend) signifi-
cantly increased risk of DM development [84]. In contrast, there
was no association between consumption of unprocessed red meat
and poultry with T2DM development risk, irrespective of their
amount, (RR 1.05, 95%CI 0.85e1.30 for highest vs lowest quintile,
and RR1.12, 95%CI 0.95e1.32 for highest vs lowest quintile,
respectively) in a large 12 years follow-up study [85]. Only con-
sumption of the 3 processed meat items and hamburgers (RR 1.27,
95%CI 0.99e1.62 for 2/week vs < 1/month) had significant asso-
ciation with T2DM risk. Frequent consumption of processed meat
was associated with a higher risk for T2DM (RR 1.46, 1.14e1.86 for
5/week vs < 1/month, p for trend <0.0001) [85].
In 24,182 participants from The United States National Health
and Nutrition Examination Survey (NHANES), 3 dietary patterns
(DP) were studied: 1) with dominant content of saturated fat (SFA),
total fat, mono-unsaturated fatty acids (MUFA) and carbohydrate
(CHO), 2) with high level of vitamins, trace elements and dietary
fiber, and, 3) mainly based polyunsaturated fatty acids (PUFA),
cholesterol and protein [86]. The first and third DP had better as-
sociation with higher likelihood for developing IR, whereas they protein, animal versus vegetable, in modifying cardiometabolic risk
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quarters of the first DP, the significant increase of mean levels of
markers of glucose and insulin homeostasis was observed - for
plasma insulin (12.3 vs 15.5 mU/mL), HbA1c (5.6 vs 5.8%), HOMA-IR
(3.3 vs 4.1), homeostatic model assessment of b-cell function
(HOMA-B) (143.5 vs 164.7), and decreased for homeostatic model
assessment of insulin sensitivity (HOMA-S) (0.58 vs 0.49) (all
p < 0.001) [86]. The opposite pattern was observed across quarters
of the second DP, as FBG (102.2 vs 99.1 mg/dl), plasma insulin (14.5
vs 12.7 mU/mL), HbA1c (5.8 vs 5.4%), 2 h glucose (123.1 vs115.4 mg/
dl), HOMA-IR (3.9 vs 3.3) decreased while HOMA-S (0.50 vs 0.58)
increased (all p < 0.001). The profiles of parameters of glucose and
insulin homeostasis were similar across quarters of the first and
third DP, and the changes in HOMA-B and HOMA-S were not sig-
nificant. This finding documented that the DP based on carbohy-
drates, SFA, PUFA, protein, total fat, MUFA, and high-cholesterol-
load foods are linked to impaired glucose tolerance. In contrast,
the healthy pattern (DP2) may have favourable effects on insulin
sensitivity and glucose tolerance [86].
After extracting and analyzing data from NHANES (n ¼ 16,784),
Mazidi et al. concluded that energy intake and race-adjusted mean
of serum CRP (0.49e0.26 mg/dl), apo B (95.6e90.8 mg/dl), glucose/
insulin homeostasis parameters and TG-glucose index (TyG) index
(8.32e7.95) significantly decreased with the increased of nut intake
(p < 0.001 for all) [87]. In a systematic review of RCTs, the relation of
nut consumption and their effect on IR and other cardiometabolic
risk factors were studied [88]. The possible mechanism of nuts in
glucose control and appetite suppression was considered to be the
activity of unsaturated fatty acids (MUFA and PUFA) that are pre-
sent in nuts. On the other hand, the fiber and polyphenols that are
compounds of nuts may also have an anti-diabetic effect by altering
gut microbiota. Nuts also lower serum cholesterol by reducing
cholesterol absorption, and through inhibition of HMG-CoA
reductase and increasing bile acid production by stimulation of 7-
a hydroxylase. Moreover, the arginine and magnesium that are
present in nuts improve inflammation, oxidative stress, endothelial
function and BP [88]. In a randomized parallel trial, in the subjects
with prediabetes who consumed for 16weeks almonds (60 g/day of
pre-packaged raw or dry roasted almonds) the fasting insulin
concentrations (23 vsþ 19%; p¼ 0.002), HOMA-IR (25 vsþ 0.3%;
p ¼ 0.007) and the homeostasis model analysis for beta-cell func-
tion (HOMA-B; 18 vs þ 30.0%; p ¼ 0.001) were significantly
reduced. Also, the glucose levels were improved by a Mediterra-
nean diet rich in pistachios (8.8 ± 8.5% p < 0.001) [88] (Figs. 1e4,
Table 8, Suppl. Table 1).
7. Dietary protein intake and CVD
Protein-based diets have become more popular with the rise of
low-carbohydrate diets. People who consume high-protein diets
oftenmiss out on the other nutrients including vegetables, legumes
and whole grains. On the other hand, some high-protein diets alsoTable 8
Recommendations for dietary protein intake and diabetes mellitus.
Class Level Daily dose of plants vs. animal Effect on DM parameters Additio
I A 14.2e68 g/day (nuts) YFG, YHbA1C, YHOMA-IR,
YHOMA-B
YSBP, Y
III A 1-7 servings/week (red and
processed meat)
[ risk for T2DM up to 50% [BW, [
Abbreviations: DM, diabetes mellitus; FG, fasting glucose; HbA1C, glycated haemoglob
meostatic model assessment of B-cell function; TC, total cholesterol; LDL-C, low density li
reactive protein; WC, waist circumference; NO, nitric oxide.
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factors: A position paper from the International Lipid Expert Panel (ILEP)contain higher levels of saturated and trans-fats, which have been
documented to associate with CHD [3,19,89,90]. Furthermore,
when the intake is in excess, proteins increasemuscle tissue acidity,
which itself contribute to oxidative stress and therefore deteriorate
vascular function and myocardial contractility. In some experi-
mental studies, the animal protein ingestion raised serum choles-
terol level, but it was not consistent in other studies. Some ecologic
studies suggested a positive association between animal protein
intake and increased risk of CHD, but the prospective data on this
association are not definite [3,8,19,90].
According to recent data [89], globally dietary risks were
responsible for 11million deaths, or 22% of all deaths among adults,
with CV disease being the leading cause. Moreover, the healthy
foods and nutrients consumption based on recent data was sub-
optimal worldwide. While, the daily intake of some unhealthy
foods and nutrients (e.g. sugar-sweetened beverages, processed
meat and sodium) exceeded the optimal level globally, the healthy
foods (nuts and seeds, milk, and whole grains) were observed to be
far from optimal intake [89]. High intake of sodium was evidenced
to be responsible for more than half of diet-related deaths and two-
thirds of diet-related disability-adjusted life-years (DALYs) in (3
million [95%Cl: 1e5] deaths and 70million DALYs), followed by low
intake of whole grains (3 million deaths and 82 million DALYs), and
low intake of fruits (2 million deaths and 65 million DALYs). These
data documented that the improvement of diet can potentially
prevent 1 in every 5 deaths worldwide [84]. It was shown that the
suboptimal diet is responsible for more deaths than any other risk
globally, including smoking, highlighting the need for urgent
improvementworldwide. This data also showed among dietary risk
factors for mortality, the diets high in sodium, low in whole grains,
low in fruit, low in nuts and seeds, low in vegetables, and low in
omega-3 fatty acids are the leading factors; each accounting for
>2% of global deaths [89].
The Nurse's Health prospective study followed 84,136 women
aged 30e55 years without known cancer, DM, ischaemic heart
disease, stroke, stroke or other CVD for 26 years follow-up [22].
A standardized and validated questionnaire, which was updated
every 4 years, was used to assess the diet in study patients.
From study subjects, 2210 incident nonfatal myocardial in-
farctions and 952 deaths from CHD were documented [22]. In
another study, higher intakes of red meat and high-fat dairy
products significantly increased risk of CHD, whereas higher
intakes of poultry, fish, and nuts were significantly lowered risk
[19]. In a model controlled statistically for energy intake, 1
serving/day of nuts lower risk of CHD for 30% (95% CI, 17e42%)
compared with 1 serving/day of red meat. Similarly, 1 serving/
day of low-fat dairy (13%; 95%CI, 6e19%), poultry (19%; 95%CI,
3e33%) and fish (24%; 95%CI, 6e39%) lowered the risk for CHD
compared with 1 serving/day of red meat. From the above data,
it is suggested that high red meat intake increases the risk of
CHD, which may be reduced by shifting sources of protein in the
US diet. However, there was no relationship between animal ornal effects Vascular effect
DBP, YTC, YLDL-C, YTG, YBW, YhsCRP Yoxidative stress, [NO, [vasodilation,
modulate gene expression of leucocyte
adhesion molecule.
WC, [LDL-C, [TC, [risk of stroke Iron-mediated oxidative stress,
[vascular stiffness
in; HOMA-IR, homeostatic model assessment of insulin resistance; HOMA-B, ho-
poprotein cholesterol; TG, triglycerides; BW, body weight; hsCRP, high sensitivity C-
y protein, animal versus vegetable, in modifying cardiometabolic risk
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unsaturated and saturated fats were included in multivariable
model analysis. But, the analyses of individual protein sources
showed that higher intake of the red and processed meats
increased, whereas higher intakes of fish, nuts, and beans
decreased the risk for CHD [22].
In another prospective cohort study, 80,082 women aged 34e59
years and without a previous diagnosis of cancer, stroke, CHD,
hypercholesterolemia or DM, the association between dietary
protein intake and incidence of CHD was examined [90]. Validated
dietary questionnaires were used to assess the intakes of protein
and other nutrients. During 14 years of follow-up, 939 major CHD
events had the study subjects [90]. After adjustment for age, higher
intake of protein lowered the risk of CHD (RR; 0.75 (95%CI: 0.61,
0.92)) differed between extreme quintiles of total protein intake
[90]. These data did not confirm the hypothesis that a high protein
intake increases the risk of CHD. In contrast, the findings of this
study suggest that replacing carbohydrates with protein may lower
the risk for CHD. However, the application of public dietary advice
for these findings should be cautious, because the high protein diet
is often accompanied by intakes with increased amount of satu-
rated fat and cholesterol [90].
The Women's Lifestyle and Health cohort study [91] with e
follow-up for 12 years of 42,237 random volunteer women (30e49
years old) in Sweden completed an extensive questionnaire. The
results of this study showed that decreasing carbohydrate or
increasing protein intake by one decile increased total mortality for
6% (95%CI: 0e12%) and 2% (95%CI: 1 to 5%), respectively [86]. The
investigators of this study mainly draw attention to the potential
for long-term adverse health effects of diets low in carbohydrates
and high in protein, related to the CV health. However, the main
limitation of this study was that it did not address questions con-
cerning the potential effects of low carbohydrate and/or high pro-
tein diets on the body weight or IR [91].
The NHANES 1999e2000 provides evidence that lower carbo-
hydrate diets have an unfavourable association with overall and
cause-specific mortality [16]. Nearly 25,000 subjects were followed
up (mean follow-up 6.4 years) and it was found that participants
with the lowest carbohydrate intake had the highest risk of overall
(32%), CVD (50%), cerebrovascular (51%) and cancer (36%) mortality,
particularly among obese participants [16]. Also, the pooled data
from 9 prospective studies [16] showed that there was an impor-
tant association between low-carbohydrate/high protein diet and
overall (RR 1.22, 95%CI 1.06e1.39, p < 0.001), CVD (RR 1.13, 95%CI
1.02e1.24, p < 0.001), and cancer mortality (RR 1.08, 95%CI
1.01e1.14, p ¼ 0.02) [16].
The Health Professionals Follow-Up Study investigated the in-
takes of protein and other nutrients and the incidence of CHD in
43,960 men using a validated food-frequency questionnaire at 4
time points during the 18 years follow-up [27]. The RR of CHD was
1.08 (95%CI: 0.95, 1.23; p for trend ¼ 0.30) when the top and the
bottom quintiles of percentage of energy from total protein were
compared. The RRs for animal and vegetable proteinwere 1.11 (95%
CI: 0.97, 1.28; p for trend ¼ 0.18) and 0.93 (95%CI: 0.78, 1.12; p for
trend ¼ 0.49), respectively. When the population was restricted to
subjects free of HTN, hypercholesterolemia, and DM at baseline, the
RR of CHD was 1.21 (95%CI: 1.01, 1.44; p for trend ¼ 0.02) for total
protein, 1.25 (95%CI: 1.04, 1.51; p for trend ¼ 0.02) for animal pro-
tein, and 0.93 (95%CI: 0.72, 1.19; p for trend ¼ 0.65) for vegetable
protein [27].
The Shanghai Women's Health Study, a prospective population-
based cohort study, investigated the effect of soya food intake on
the incidence of CHD among 75,000 Chinese women, of whom
64,915 were without previously diagnosed CHD, DM, stroke or
cancer at baseline, using a validated food-frequency questionnairePlease cite this article as: Zhubi-Bakija F et al., The impact of type of dietar
factors: A position paper from the International Lipid Expert Panel (ILEPin an in-person interview on usual intake of soya food (40e70
years) [23]. There was a significant dose-response relationship
between soy food intake and risk of total CHD (p-trend ¼ 0.003)
with an adjusted RR of 0.25 (95%CI, 0.10e0.63) when the highest vs
the lowest quartiles of total soya protein intake were compared.
This association was highly significant for nonfatal myocardial
infarction (RR ¼ 0.14; 95%CI, 0.04e0.48; p for trend ¼ 0.001). In
conclusion, this study found that soy food consumptionmay reduce
the risk of CHD in women [23].
Kelemen et al. prospectively followed for 15 years the incidence
of cancer and mortality from CHD, cancer, and all causes in 29,017
postmenopausal Iowa women without previous CHD, CHD or DM,
who responded to a mailed questionnaire for their medical infor-
mation, dietary and lifestyle [92]. The risk ratios from a simulated
substitution of dietary protein with carbohydrate and of vegetable
with animal protein were estimated by nutrient density models.
The authors found that the highest vegetable protein intake
decreased CHD mortality by 30% among women, from an iso-
energetic substitution of vegetable protein for carbohydrate and for
animal protein [(95%CI: 0.49, 0.99) and (95%CI: 0.51, 0.98),
respectively] following multivariable adjustment [92]. Moreover,
the red meat intake was associated with CHD mortality (Risk Ratio
1.44, 95%CI: 1.06, 1.94) and dairy products (Risk Ratio 1.41, 95%CI:
1.07, 1.86) when substituted for servings per 1000 kcal (4.2 MJ) of
carbohydrate foods. The results of this study showed that the long-
term adherence to high-protein intake diets, without discrimina-
tion toward protein source, may have potentially adverse health
consequences [92].
According to a study by Mazidi et al., dietary patterns play an
important role on serum hsCRP levels, as a risk factor for CVD [93].
More than 17,000 participants were selected and analyzed. It was
found that dietary fiber intakes, PUFA, vitamins A, E, B family, C and
K total folate magnesium, iron, copper and potassium decreased
hsCRP (p < 0.001 for all), whereas sugar intake increased hsCRP
levels (p < 0.001) [93]. The data from the selected participants of US
NHANES were used to assess the association of the Dietary In-
flammatory Index (DII) scores with different cardio-metabolic risk
factors and their combination as MetS [94]. The energy-adjusted-
DII (E-DII) expressed per 1000 kcal was calculated from 24 h di-
etary recalls. Of the 17,689 participants (mean age was 45.8 years),
48.3% were men, who were slightly younger than women (44.9 vs
46.5 years, p ¼ 0.05). The odds of MetS, its components, as well as
obesity, elevated hsCRP, TG/HDL-C ratio, apo B and HbA1c rose
across increasing quartiles of E-DII (p < 0.001). In the models that
were adjusted for age, sex, race and income-to-poverty ratio, the
CVD risk factors (TG/HDL-C ratio, apo B and HbA1c) were increased
across quartiles of the E-DII (all p < 0.001), while HDL-C levels
decreased (p < 0.001) [94].
In a study with national representative sample of American
adults, the association between dietary acid load, potential renal
acid load (PRAL) and net endogenous acid production (NEAP) on
one hand, and PAD on the other hand, was investigates [95]. Of
4864 eligible participants (40e85 years old), (5.5%) had PAD
confirmed by ankle brachial index <0.9 in either limb. Patients with
PAD had highermean of PRAL and NEAP (16.2 vs 9.1mEq/d and 56.2
vs 50.1 mEq/d), p < 0.001 for both, compared with PAD-free par-
ticipants. The top, more acidic, quarter of PRAL was associated with
31% higher odds comparedwith the bottom quarter (more alkaline)
[OR: 1.31, 95%CI: 1.11e1.57] regarding the presence of the PAD. The
findings of this study suggest that dietary acids load, which is an
index of acid-base balance, may contribute to the pathogenesis of
PAD [95].
From 24,474 participants, 3520 deaths occurred during follow-
up in cohort study [96], which examined the association of total
dairy and dairy subgroups consumption of with total and causey protein, animal versus vegetable, in modifying cardiometabolic risk
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tality risk was lower when the top quartiles were compared with
the lower quartiles of total dairy (hazard ratio [HR] 0.98, 95%CI:
0.95e0.99) and of cheese (HR: 0.92, 95%CI: 0.87e0.97) consump-
tion. Using a similar model, the total dairy and milk consumption
had a negative association with the risk of cerebrovascular mor-
tality (HR: 0.96, 95% CI: 0.94e0.98, HR: 0.93, 95% CI: 0.91e0.96,
respectively), while milk consumption was associated with
increased CHD mortality (HR: 1.04, 95%CI: 1.02e1.06) [96]. The
authors next carried out a systematic review and meta-analysis
with 636,726 participants of prospective studies to check the
consistency with their cohort study. The results of this meta-
analysis documented a significant inverse association between
fermented dairy products and all-cause mortality (RR: 0.97, 95%CI:
0.96e0.99), while milk consumption was associated with higher
CHD mortality (RR: 1.04, 95%CI: 1.01e1.05) [96] (Figs. 1e4, Table 9,
Suppl. Table 1).8. Dietary protein intake and stroke
The results from 4 cohort studies [97e100], which evaluated the
relationship between dietary protein consumption and strokes,
showed that higher consumption of red meat (both processed and
unprocessed), refined grains and full-fat dairy products intakes
were associated with a higher risk of stroke. On the other hand,
higher intakes of fruits, vegetables, whole grains, fish, and poultry
lowered the risk of stroke events. A study that involved 84,010
women and 43,150 men, compared the effects of red meat with
different protein sources, found that the risk of stroke was lowered
by 1 serving/day of: poultry for 27% (95%CI, 12e39%), nuts for 17%
(95%CI 4e27%) fish for 17% (95%CI, 0e30%), low-fat dairy for 11%
(95%CI, 5e17%), and whole-fat dairy for 10% (95%CI, 4e16%),
compared with 1 serving/day of red meat [97]. On the other hand,
there was no significant associations were seen with exchanging
legumes or eggs for red meat [97]. In the 3 other studies, with
150,000 individuals, the interaction of total, animal, and vegetable
protein on one hand, with HTN, DM, hypercholesterolemia and
high BMI on the other hand, were examined [98e100]. In the study,
with 34,670 women without CVD and cancer at baseline who were
prospectively followed up for 10.4 years, 1680 incident cases of
stroke (cerebral infarctions, intracerebral haemorrhages, sub-
arachnoid haemorrhages and unspecified strokes) were ascer-
tained [98]. The diets with high total red meat and processed meat
intake increased the risk of cerebral infarction, but not of total
stroke, intracerebral haemorrhage or subarachnoid haemorrhage.Table 9
Recommendations for dietary protein intake and CV risk.
Class Level Substitute 1 serving/day of red meat
I B Substitute with fish
I B Substitute with poultry
I B Substitute with low-fat dairy
IIa B Substitute with nuts
Abbreviations: CHD, coronary heart disease, CV, cardiovascular.
Please cite this article as: Zhubi-Bakija F et al., The impact of type of dietar
factors: A position paper from the International Lipid Expert Panel (ILEP)The multivariable RR of cerebral infarction, when the highest
quintile was compared with the lowest quintile of consumption
was 1.22 (95%CI, 1.01e1.46) for redmeat and 1.24 (95%CI, 1.04e1.49)
for processed meat. However, unprocessed (fresh) meat con-
sumption did not correlated with total stroke or with any stroke
subtypes [98].
In a study, which assessed the association between dietary
protein, intake and risk of stroke among middle-aged men (43,960
participants followed up for 18 years) 1057 stroke events were
identified [100]. When the risk for total stroke, the top quintile of
percentage energy from protein were compared with the bottom,
the RR was 1.14 (95%CI: 0.90, 1.43; p for linear trend: 0.43) for total
protein, 1.11 (95%CI: 0.87, 1.41; p for linear trend: 0.52) for animal
protein, and 0.82 (95%CI: 0.60, 1.12; p for linear trend: 0.17) for
vegetable protein. There was no difference between protein intake
and subtypes of stroke - ischemic and haemorrhagic ones [100].
The prospective study by Fung et al., investigated major dietary
patterns and stroke risk in 71,768 women (38e63 years old)
without a previous history of CVD or DM [99]. The results
demonstrated that a high Western dietary pattern score (high
intake of red and processed meats, refined grains, high-fat dairy
products, and sweets and desserts) increased the risk of ischemic
stroke. In contrast, a reduced risk of ischemic stroke was observed
in participants that used a high prudent pattern score (higher in-
takes of fruits, vegetables, whole grains, fish and poultry). During
14 years of follow-up, when comparing the highest with lowest
quintiles of the Western pattern, after adjusting for potential con-
founders, a RR of 1.58 (95%CI, 1.15 to 2.15; p ¼ 0.0002 for trend) for
total strokes and 1.56 (95%CI, 1.05 to 2.33; p ¼ 0.02 for trend) for
ischemic stroke. On the other hand, in participants that used pru-
dent pattern, when the extreme quintiles were compared the RRs
were 0.78 (95%CI, 0.61 to 1.01) for total stroke and 0.74 (95%CI, 0.54
to 1.02) for ischemic stroke [99].
The relationship between the red meat consumption and the
risk of stroke was assessed among 40,291 Swedish men (45e79
years old), without previous history of CVD or cancer at baseline
[101]. The consumption of processed meat increased the risk of
stroke, whereas the consumption of fresh red meat has no rela-
tionship with the risk of stroke. The multivariable RRs of total
stroke were 1.23 (95%CI: 1.07, 1.40; p for trend ¼ 0.004) for pro-
cessed meat and 1.07 (95%CI: 0.93, 1.24; p for trend¼ 0.77) for fresh
red meat, when comparing the highest with the lowest quintiles of
these intakes. The results of this study documented that processed
meat consumption was positively associated with risk of cerebral
infarction, when the highest with the lowest quintile of theseThe effect on the risk of CHD Mechanism of action
Y 24% Y Saturated fat content
Y Heme iron content
YSalt content
[Polyunsaturated fat
Y 19% Y Saturated fat content
Y Heme iron content
YSalt content
[Polyunsaturated fat
Y 13% Y Saturated fat content
Y Heme iron content
YSalt content
[Polyunsaturated fat
Y 20e30% Y Saturated fat content
Y Heme iron content
YSalt content
[Polyunsaturated fat
y protein, animal versus vegetable, in modifying cardiometabolic risk
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Table 10
Recommendations for dietary protein intake and stroke.
Class Level Daily doses of dietary proteins The effect on the risk of stroke Vascular effects
III A 100 g increment/day in total meat consumption [10% Iron-mediated oxidative stress,
[vascular stiffness
III A 100 g increment/day in red meat consumption [13% Iron-mediated oxidative stress,
[vascular stiffness
III A 50 g increment/day in processed meat consumption [11% Iron-mediated oxidative stress,
[vascular stiffness
I B Substitute 1 serving of red meat with poultry/day Y 27% Y saturated fat,
Y vascular fragility
I B Substitute 1 serving of red meat with fish/day Y 17% Ysaturated fat,
Y vascular fragility
I B Substitute 1 serving of red meat with nuts/day Y 17% Ysaturated fat,
Y vascular fragility
I B Substitute 1 serving of red meat with low-fat dairy/day Y 11% Ysaturated fat,
Y vascular fragility
I B Substitute 1 serving of red meat with whole-fat dairy/day Y 10% Ysaturated fat,
Y vascular fragility
F. Zhubi-Bakija et al. / Clinical Nutrition xxx (xxxx) xxx18consumptions were compared [(RR: 1.18; 95%CI: 1.01, 1.38; p for
trend ¼ 0.03) 101].
A meta-analysis of pooled data from prospective cohort studies
evaluated the association between consumption of red and pro-
cessedmeat and risk of stroke [102]. This analyses documented that
in individuals with the highest intakes of total, red or processed
meat increased the risk of stroke, compared with individuals with
the lowest intakes; the RRs were: 1.15 (95%CI, 1.05e1.25) for total
meat, 1.09 (95%CI, 1.01e1.18) for red meat and 1.14 (95%CI,
1.05e1.25) for processed meat. The relationship between red meat
consumption and ischemic and haemorrhagic strokes had pooled
RRs 1.13 (95%CI, 1.01e1.25) and 0.99 (95%CI, 0.77e1.28), respec-
tively. The RRs of the relationship between processed meat con-
sumption and ischemic and haemorrhagic strokes were 1.19 (95%CI,
1.08e1.31) and 1.23 (95%CI, 0.96e1.58), respectively [102]. The re-
sults from this analysis showed that each 100 g/day increment in
total meat consumption increased the risk of stroke by 10%
(RR¼ 1.10; 95%CI, 1.05e1.15), each 100 g/day increment in redmeat
consumption by 13% (n¼ 5; RR¼ 1.13; 95%CI, 1.03e1.23) and by 11%
for each 50 g/day increment in processedmeat consumption (n¼ 5;
RR ¼ 1.11; 95%CI, 1.02e1.20) [102]. Another meta-analysis of pro-
spective studies evaluated the effects of red meat consumption on
the risk for stroke [103]. There were 10,630 cases of stroke among
329,495 participants from 6 prospective studies with follow-up
from 11 to 26 years. The RR (95%CI) of all strokes were 1.11
(1.03e1.20), 1.13 (1.03e1.24), and 1.11 (1.06e1.16), respectively, for
each serving/day increase in fresh red meat, processed meat and
total red meat consumption. The stroke subtypes, however had
different results regarding these associations: while the risk of
ischemic stroke was positively associated with consumption of
fresh red meat (RR, 1.13; 95%CI, 1.00e1.27), processed meat (RR,
1.15; 95%CI, 1.06e1.24), and total red meat (RR, 1.12; 95%CI,
1.05e1.19); these intakes had no significant associations with
haemorrhagic stroke [103] (Figs. 1e4, Table 10, Suppl. Table 1).
9. Conclusions and implications for future studies
Many observational and interventional studies confirmed that
increasing protein intake, especially plant-based proteins and some
selected animal-based proteins (poultry, fish, unprocessed red
meat low in saturated fats and low-fat dairy products) have a
positive effect in modifying cardio-metabolic risk factors. Never-
theless, the existing evidence is not consistent enough. Vegetarians
have a tendency to have lower BP, healthier lipid profiles and
almost near normal body weight, compared with omnivores, even
though this may be a result of their overall healthier lifestyle. InPlease cite this article as: Zhubi-Bakija F et al., The impact of type of dietar
factors: A position paper from the International Lipid Expert Panel (ILEPmany studies red meat intake has been correlated with increased
CVD risk, mainly because of its non-protein ingredients (saturated
fats) and theway it was cooked and preservedmatters. So, there are
recommendations to substitute red meat for poultry or fish, in or-
der to lower CVD risk. As specific amino acids have antihyperten-
sive effect, foods that contain these amino acid-rich-proteins have
favourable results in modifying a major risk factor for CVD, such as
hypertension.
A considerable number of RCTs attribute cardioprotective
properties to soya consumption. Soya might improve the lipid
profile and adjust BP, even though it is not clear whether this is the
effect of soybean proteins or isoflavones. Despite that, soya remains
a favourable protein source. Regarding dairy products, proteins
found there (especially whey protein) are inversely correlated with
hypertension, obesity and insulin resistance. In order to reduce CVD
risk factors, evidence-based dietary patterns should be promoted.
Replacing carbohydrates and unprocessed red meat with protein-
sufficient foods that have been shown to have advantageous out-
comes, is advised. Dietary recommendations should provide
emphasis to both the amount and sources of protein.
As it is very difficult to determine the effect of a specific protein
in a certain food, without the interference of the effects of other
accompanying ingredients, there is a lack of human or animal
studies that provides definitive results regarding their effects.
There is also a need for more studies that evidence the health
outcomes of other plant-based proteins, other than soy and nuts.
Due to the fact that it is impossible to investigate the effect of di-
etary proteins only on health outcomes, we still cannot exclude the
possibility that their favourable effects in lowering CVD risk could
be due to isoflavones or unsaturated fats (or other dietary com-
ponents) [104e106].
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